Posts in tag

liver health


With many of Australia’s pharmacists descending on Sydney to attend the PSA19 conference, it’s been a very busy week in the world of pharmacy… At the conference, Health Minister Greg …

What impact can pharmacists have on the uptake of DAAs? asks Carlene McMaugh Hepatitis C is now in a unique category of conditions where we have a medication that can …

Direct-acting antivirals are associated with reduced risk of mortality and liver cancer, according to results from the first prospective, longitudinal study investigating their use in treating chronic hepatitis C The …

Deaths from hepatitis C have dropped by a fifth, highlighting the importance of new treatments and their affordability New Kirby Institute data presented at the Australasian Viral Hepatitis Conference in …

The number of Australians receiving breakthrough antiviral therapy to cure hepatitis C has sharply declined This has prompted appeals for more Australians living with the virus to come forward to …

Guild Learning and Development is partnering with Gilead Sciences in an online course The course is titled Management of Hepatitis C and the role of pharmacy. Hepatitis C (HCV), a …

Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, …

People treated with new direct acting antivirals feel old and new hepatitis C treatments are “like chalk and cheese” On World Hepatitis Day today (28 July), Hepatitis NSW is promoting …

The first and only one-tablet, once-a-day treatment for all genotypes of chronic hepatitis C infection has been recommended for PBS listing Gilead Sciences Australia has announced that the TGA has …

Debbie Rigby rounds up the latest in research news Optimizing identification and management of COPD patients – reviewing the role of the community pharmacist This paper proposes key steps for …

Weekly Dose: sofosbuvir – what’s the price of a hepatitis C cure? Greg Dore, UNSW Australia and Marianne Martinello, UNSW Australia Sofosbuvir is one of a number of new direct-acting …

Community pharmacies across Australia have played a significant role in the outstanding progress made in the treatment of Australians with hepatitis C since the listing of new medicines in March …